Media Room

For More Information Contact

For Media Inquiries:

Dana Korsen
Phone:
202-334-2843
Fax:
202-334-2843
E-mail:
dkorsen@nas.edu

Mailing Address

The National Academies of Sciences, Engineering, and Medicine

Health and Medicine Division

500 Fifth St, NW
Washington, DC 20001

News and Announcements

The latest news from HMD, including information about new reports, activities, meetings, and other noteworthy events.


News Release

Press Release: Urgent Change Needed to Improve Diagnosis in Health Care or Diagnostic Errors Will Likely Worsen, Says New Report
Released: 9/22/2015

Most people will experience at least one diagnostic error -- an inaccurate or delayed diagnosis -- in their lifetime, sometimes with devastating consequences, says a new report from the Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine.

Report at a Glance

  • Figures (HTML)
  • Report in Brief (PDF)
  • List of Recommendations (PDF)
  • Resources for Improving Communication (PDF)
  • Resources for Improving Communication (Spanish) (PDF)
  • Cover Image and Citation Slide (HTML)
Reports: Related Reports
Activities: Related Activities

News Release

Health Care Wait Times Vary Greatly Throughout U.S.; New IOM Report Calls for Putting Patients and Families First Using Approaches Applied Successfully in Other Sectors
Released: 6/29/2015

Tremendous variability in wait times for health care appointments exists throughout the U.S., ranging from same day service to several months, says a new report from the Institute of Medicine.

Report at a Glance

  • Report Brief (PDF)
  • Key-Findings-Recommendations (PDF)
  • Key Principles (PDF)
Reports: Related Reports
Activities: Related Activities

News Release

Creation of a Central Management Plan for Every New Drug Needed to Strengthen FDA's Oversight of Approved Drugs' Safety
Released: 5/1/2012

Although the approval of a new drug is based on evidence that its benefits outweigh its risks, the full range of a medication's effects may not become apparent until a product has been used by a larger, more diverse population over an extended period of time. Problems associated with the anti-diabetes drug Avandia, pain reliever Vioxx, and cholesterol-reducing drug Crestor illustrate the challenges and underscore the need for a more systematic and transparent process to collect, assess, and act on data about a medication's benefit-risk profile throughout its entire "life cycle" from approval until it is no longer marketed, says a new report by the Institute of Medicine.

Report at a Glance

Reports: Related Reports
Activities: Related Activities

News Release

IOM Elects 65 New Members, Five Foreign Associates
Released: 10/17/2011

The IOM announced the names of 65 new members and five foreign associates on October 17 in conjunction with its 41st annual meeting. Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

Reports: Related Reports
Activities: Related Activities

News Release

Few Health Problems Are Caused By Vaccines, IOM Report Finds
Released: 8/25/2011

An analysis of more than 1,000 research articles concluded that few health problems are caused by or clearly associated with vaccines, according to a new IOM report.

Report at a Glance

  • Graphic: Strength of Evidence that Determined the Causality Conclusions (PDF, HTML)
  • Press Release (HTML)
  • Report Brief (PDF, HTML)
  • Table: Summary of Causality Conclusions (PDF)
Reports: Related Reports
Activities: Related Activities

News Release

Experts Explore Digital Technologies' Potential to Improve Health Care
Released: 5/23/2011

Digital technology is transforming many arenas, including health care. The new proceedings of a series of workshops held by the IOM in 2010 presents the insights and perspectives of a range of experts on what is necessary to enable health care professionals and organizations to harness the full potential of new digital technologies to increase efficiency and generate and apply knowledge to real-time care decisions.

Reports: Related Reports
Activities: Related Activities

News Release

Health Experts’ Insights on Promising Methods To Improve Health Care Value Summarized in New Report
Released: 2/24/2011

Health care spending is one of the fastest growing contributors to government debt. According to the Congressional Budget Office, federal spending on health care will double in the next 10 years, consuming 27 percent of the budget by 2020. A new workshop summary from the Institute of Medicine presents expert insights from physicians, nurses, patients, hospital administrators, health economists, employers, insurers, and others on the size and nature of wasted resources in the health care system and how to improve health care value.

Reports: Related Reports
Activities: Related Activities

News Release

Report Offers FDA A Framework for Evaluating Ethical Issues When Deciding Whether to Require Postmarketing Studies of Drugs
Released: 7/9/2010

A new letter report from the IOM recommends a conceptual framework to help the U.S. Food and Drug Administration evaluate the ethical issues involved in determining whether companies should start or continue clinical trials on approved drugs and in ensuring that these studies are ethically conducted. FDA has recently gained enhanced authority to require drug companies to undertake studies of their products after they are put on the market, which presents the agency with additional challenges.

Report at a Glance

  • Press Release (HTML)
Reports: Related Reports
Activities: Related Activities

News Release

IOM Report Recommends Framework to Evaluate Science Behind Health Claims for Foods and Drugs; Calls for Equal Rigor in Assessing Food Claims and Drug Approvals
Released: 5/12/2010

The U.S. Food and Drug Administration (FDA) should apply the same rigor to evaluating the science behind claims of foods' and nutritional supplements' health benefits as it devotes to assessing medication and medical technology approvals, says the IOM's report Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease.

Report at a Glance

Reports: Related Reports
Activities: Related Activities